Full text is available at the source.
Abstract
The updated consensus statement emphasizes the holistic management of type 2 diabetes, addressing multiple long-term conditions.
- A systematic review of publications since 2022 informed new recommendations for managing type 2 diabetes.
- The focus has shifted from solely managing high blood sugar to a broader view that includes overall health and lifestyle.
- Key elements of effective diabetes care now include promoting healthy eating, physical activity, and psychological support.
- Early use of sodium-glucose cotransporter 2 (SGLT2) inhibitors or glucagon-like peptide-1 (GLP-1) therapies is recommended to improve long-term health outcomes.
- Combination therapy with SGLT2 inhibitors and GLP-1-based therapies may be beneficial for patients with cardiovascular disease, chronic kidney disease, or heart failure.
Simplified